Theramex Treatment for Osteoporosis in Postmenopausal Women Accepted by Scottish Medicines Consortium

Theramex Treatment for Osteoporosis in Postmenopausal Women Accepted by Scottish Medicines Consortium

The company estimated that more than 1000 women in Scotland at very high risk of fracture would be eligible for treatment.

SMC recommends Eladynos for postmenopausal osteoporosis in Scotland - Pharmafile

Theramex, a women’s health pharma company, has announced that the Scottish Medicines Consortium has recommended Eladynos (abaloparatide) for NHS use in Scotland. This offers a new treatment option for postmenopausal women at high risk of fracture. Osteoporosis is a progressive condition causing fragile bones and fractures. Hip fractures alone are responsible for around 50% of […] The post SMC recommends Eladynos for postmenopausal osteoporosis i…